Health Care & Life Sciences » Biotechnology | D. Western Therapeutics Institute Inc.

D. Western Therapeutics Institute Inc.

D. Western Therapeutics Institute Inc.
Stock Exchange Tokyo Stock Exchange
EPS
 JPY23.07
Market Cap
 JPY11.69 B
Shares Outstanding
 26.28 M
Public Float
 18.87 M

Profile

Address
CK21 Hirokoji-Fushimi Building, 7/F
Nagoya Aichi 460
Japan
Employees -
Website http://www.dwti.co.jp
Updated 09/14/2018
D. Western Therapeutics Institute, Inc. engages in the research and development of pharmaceutical drugs. Its products include ophthalmic solution and agents for anti-platelet and anti-glaucoma.

Financials

View All
Created with Highcharts 5.0.14D. Western Therapeutics Institute Inc.Net Income. Fiscal year is January-December. All values JPY Thousands.222 171222 171192 642192 642296 471296 471253 515253 5151 563 4981 563 498201320142015201620170500k1 000k1 500k2 000k
Created with Highcharts 5.0.14D. Western Therapeutics Institute Inc.Sales/Revenue. Fiscal year is January-December. All values JPY Thousands.80 00080 00080 02580 02561 81861 818168 002168 002254 028254 02820132014201520162017050k100k150k200k250k300k

Tetsuya Kawakami
Director, Manager-Administration & General Affairs
Eisaku Nakamura
Outside Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.